Iterion Therapeutics Lands $17M Series B

19 Feb, 2021

Iterion Therapeutics Lands $17M Series B
Photo by Matthew Fournier on Unsplash

– Iterion Therapeutics, a venture-backed, clinical stage biotechnology company developing novel cancer therapeutics, has raised $17m in a Series B financing.
РThe round was led by Lumira Ventures, with the participation of existing investors, including Sant̩ Ventures, as well as new investors Venture Investors, GPG Ventures, and Viva BioInnovator.

Biotechnology North America Pharmaceutical Therapeutics
Crunchbase icon

Content report

The following text will be sent to our editors: